preterm labor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Voluntary signing of the informed consent form; 2. Age >= 18; 3. Gender: Female; 4. From January 2021 to August 2024, patients treated with ritodrine alone for fetal preservation were assigned to Group A, those treated with atosiban alone as Group B, and those treated with both ritodrine and atosiban in combination as Group C at the Southern Medical University Affiliated Hospital. 5. Patients who have used ritodrine or atosiban or a combination of ritodrine and atosiban can be queried through the "Donghua Official Database" at the Southern Hospital.
Exclusion criteria
Exclusion criteria: 1. Individuals with cervical dysfunction; 2. Pregnancy >= 37 weeks (full-term); 3. Identify individuals with fetal distress or intrauterine infection; 4. Severe prenatal bleeding, especially placental abruption, placenta previa with active bleeding; 5. Individuals with preeclampsia or eclampsia; 6. Individuals with severe cardiovascular disease; 7. Those who do not control hyperthyroidism and diabetes; 8. Because surgery requires prophylactic medication for patients; 9. The patient only has medication records, but no production records, lacking complete clinical and postpartum information;
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Neonatal birth outcomes;Effective time of symptom improvement after medication;Premature birth occurs;Gestational age at delivery;Adverse reactions after medication; | — |
Primary
| Measure | Time frame |
|---|---|
| Pregnancy duration extension; | — |
Countries
China
Contacts
Southern Medical University Southern Hospital